Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Dollerup, A. Løkke, P. B. Poulsen, G. Hansen, J. Lykke Jensen, J. Holt, B. Lavik, C. Suppli Ulrik, R. Dahl (Ballerup, Aarhus, Copenhagen, Rødovre, Hvidovre, Denmark). Potential economic savings of early detection of COPD in general praksis in Denmark. Eur Respir J 2010; 36: Suppl. 54, 5182

Member's Comments

No comment yet.

Related content which might interest you: The effect of early stages of COPD on resource use and health-care costs Source: Annual Congress 2011 - Understanding the burden of chronic respiratory diseases: what decision makers need to know Year: 2011 The economic burden of COPD in a Danish municipality Source: Annual Congress 2011 - Understanding the burden of chronic respiratory diseases: what decision makers need to know Year: 2011 Projections of future costs of asthma and COPD in the Netherlands Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005 Societal costs of severe asthma in Sweden Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018 The cost of respiratory health in Europe Source: Annual Congress 2010 - The European Lung White Book II Year: 2010 Late Breaking Abstract - Assessing epidemiology and costs of asthma and COPD in Switzerland with health insurance data Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 High rates of over-treatment of COPD in primary care: What risks to patients and costs to health services? Source: Annual Congress 2011 - Early diagnosis in primary care Year: 2011 The burden of illness and economic evaluation for COPD Source: Eur Respir J 2003; 21: 29S-35S Year: 2003 Estimating potential cost savings associated with managing COPD according to GOLD 2017 recommendations in UK primary care: a CPRD study Source: International Congress 2018 – COPD management Year: 2018 Factors influencing duration of exposure with symptoms and costs of occupational asthma Source: Eur Respir J 2010; 36: 728-734 Year: 2010 Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Health care utilization and costs of asthma and COPD in the Netherlands Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005 Lack of oximeters in primary care risks increasing the mortality from COPD Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Direct and indirect costs of COPD treatment in primary and secondary care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Health care costs associated with acute asthma: a economic analysis Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002 Lifetime costs of COPD in the Netherlands Source: Eur Respir J 2002; 20: Suppl. 38, 124s Year: 2002 Main cost drivers of costs for asthma in society - report from the obstructive lung disease in Northern Sweden studies (OLIN) Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001